Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 8:31 PM ET

Date/Time Source News Release
05/28/2025 08:00 AM EDT GlobeNewswire Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
05/08/2025 04:01 PM EDT GlobeNewswire Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
04/01/2025 07:00 AM EDT GlobeNewswire Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
02/27/2025 04:05 PM EST GlobeNewswire Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress
02/18/2025 08:00 AM EST GlobeNewswire Ventyx Biosciences Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn's Disease at ECCO 2025
02/05/2025 08:00 AM EST GlobeNewswire Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
01/14/2025 08:00 AM EST GlobeNewswire Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio
11/12/2024 07:30 AM EST GlobeNewswire Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
11/07/2024 04:05 PM EST GlobeNewswire Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Progress
10/15/2024 08:00 AM EDT GlobeNewswire Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
Page

Additional News

As of June 13, 2025 • 8:31 PM ET

Date/Time Source News Release
05/09/2025 02:27 PM EDT SeekingAlpha Ventyx Biosciences GAAP EPS of -$0.39
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Ventyx Biosciences Inc.
04/29/2025 03:26 PM EDT SeekingAlpha Viking among notable gainers as Pfizer raises deal prospects
04/17/2025 04:11 PM EDT SeekingAlpha SA Asks: What's the best weight-loss drug stock right now?
04/14/2025 11:03 AM EDT SeekingAlpha Viking, Structure, Metsera on a tear as Pfizer drops obesity pill
03/08/2025 01:30 PM EST SeekingAlpha Weight-loss drug battle: Who are the latest players involved
02/27/2025 05:37 PM EST SeekingAlpha Ventyx Biosciences GAAP EPS of -$0.41 beats by $0.12
02/25/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, February 25th, 2025
02/25/2025 04:31 AM EST US Earnings Reports Expected earnings - Ventyx Biosciences Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.